RDInvesting Provides Investors with Free In-Depth Equity Reports on FINL, LPNT, MXIM and PENNadmin
Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://www.rdinvesting.com/ and get exclusive access to our numerous stock reports and market updates.
Finish Line Inc. (NASDAQ: FINL) shares increased 3.25 percent to close at $26.33 a share Thursday. The stock traded between $25.85 and $26.66 on volume of 1.67 million shares traded. Analysts at B. Riley have recently upgraded the company’s rating to “buy” from “neutral”. Shares of Finish Line have gained approximately 39.0 percent year-to-date.
Find out more about Finish Line including full access to the free equity report at:
LifePoint Hospitals, Inc. (NASDAQ: LPNT) shares increased 2.96 percent to close at $52.44 a share Thursday. The stock traded between $51.72 and $53.58 on volume of 547,136 shares traded. Analysts at Deutsche Bank have recently upgraded the company’s rating to “buy” from “hold”. Shares of LifePoint Hospitals have gained approximately 38.0 percent year-to-date.
Find out more about LifePoint Hospitals including full access to the free equity report at:
Maxim Integrated Products Inc. (NASDAQ: MXIM) shares increased 0.07 percent to close at $29.37 a share Thursday. The stock traded between $29.22 and $29.43 on volume of 3.76 million shares traded. Analysts at Drexel Hamilton have recently initiated coverage on the company with a “hold” rating.
Find out more about Maxim Integrated Products including full access to the free equity report at:
Penn National Gaming, Inc. (NASDAQ: PENN) shares declined 0.28 percent to close at $14.50 a share Thursday. The stock traded between $14.25 and $14.85 on volume of 4.22 million shares traded. Analysts at JPMorgan have recently downgraded the company’s rating to “neutral” from “overweight”.
Find out more about Penn National Gaming including full access to the free equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Research Driven Investing
Posted: November 15th, 2013 under ACCESSWIRE.